Simsek Halis, Balaban Yasemin H, Yilmaz Engin, Sumer Hale, Buyukasik Yahya, Cengiz Cem, Ozcebe Osman, Hascelik Gulsen, Tatar Gonca
Unit of Gasroenterology, Hacettepe University, Ankara, Turkey.
Ann Hematol. 2005 Oct;84(10):646-9. doi: 10.1007/s00277-005-1048-y. Epub 2005 May 4.
Since the discovery of the HFE gene, C282Y and H63D mutations have been reported as significantly correlated with clinically manifested hereditary hemochromatosis (HH). As the other genes involved in iron metabolism have been described, non-HFE cases of HH have been identified. Since in the general Turkish population, the C282Y mutation is not found and the H63D mutation is of high frequency, we aimed to determine mutations in the HFE genes in our patients with HH. The HFE gene of the five patients with HH were sequenced. C282Y mutation was absent, and all HH patients were heterozygote for H63D mutation. No other mutation was found in HFE gene by sequencing. Although the higher allele frequency of the H63D mutation in Turkish HH patients than in the general population implies a role of the H63D mutation in iron overload, there is a strong possibility that Turkish HH patients have non-HFE hemochromatosis.
自发现HFE基因以来,已报道C282Y和H63D突变与临床表现为遗传性血色素沉着症(HH)显著相关。随着其他参与铁代谢的基因被描述,已鉴定出非HFE型HH病例。由于在土耳其普通人群中未发现C282Y突变,而H63D突变频率较高,我们旨在确定HH患者中HFE基因的突变情况。对5例HH患者的HFE基因进行了测序。未发现C282Y突变,所有HH患者均为H63D突变杂合子。通过测序在HFE基因中未发现其他突变。尽管土耳其HH患者中H63D突变的等位基因频率高于普通人群,这意味着H63D突变在铁过载中起作用,但土耳其HH患者很有可能患有非HFE型血色素沉着症。